By Nigam Arora & Dr. Natasha Arora
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.
The News
UNH is the largest health insurer in the country. Earnings of UNH will fall as seniors are choosing to do more elective surgeries. One of the beneficiaries is ZBH. ZBH is a major manufacturer of joint replacements such as knees, hips, and shoulders.
Zones
For those following the Good Way the Buy Now rating is 🔒 (To see the locked content, please take a 30 day free trial) to start a very small scale in.
For those following the Best Way, the Buy Zone is 🔒. The nature of this trade is such that it needs to be accumulated in small tranches in a wide Buy Zone. The Buy Zone may be tightened in the future. ZBH is currently trading at $142.71.
To learn about the Good Way and the Best Way, please see the Getting a Running Start Guide.
To learn about Buy Zones and scaling in, please see Trade Management Guidelines.
Recommended position size is 🔒 of the full core position size. The position size will likely be increased in the future.
This is a very long term position.
The very long term target zone is 🔒.
The catastrophic stop zone is 🔒 as the plan is to accumulate more as the stock falls. However, for those who want a closer stop the mental stop zone is 🔒.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
